Evidence method
Level · gp.fundamentals.capex_revenue_ratio
1.89% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
UTMD · Mar 31, 2025
UTAH MEDICAL PRODUCTS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001096906-25-000816General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
45.97% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-14.37% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
89.06% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
57.03% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
32.47% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.59% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.84% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History29 statesSelf-history eligible
Dec 31, 20217/9 normalizedLevel 3Mar 31, 20227/8 normalizedLevel 3Jun 30, 20227/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/9 normalizedLevel 3Dec 31, 20228/9 normalizedAmended as filedMar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/9 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/9 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/9 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.56%
- Current
- 1.89%
- Delta
- 1.33%
- Previous
- 36.26%
- Current
- 45.97%
- Delta
- 9.71%
- Previous
- -18.56%
- Current
- -14.37%
- Delta
- 4.18%
- Previous
- 21.54%
- Current
- 89.06%
- Delta
- 67.52%
- Previous
- 59.02%
- Current
- 57.03%
- Delta
- -1.99%
- Previous
- 33.23%
- Current
- 32.47%
- Delta
- -0.76%
- Previous
- 1.99%
- Current
- 1.59%
- Delta
- -0.40%
- Previous
- 0.63%
- Current
- 0.84%
- Delta
- 0.22%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · UTMD Fundamental State →Has State · UTAH MEDICAL PRODUCTS INC →Transitioned To · UTMD Fundamental State →Transitioned To · UTMD CAPEX_INTENSITY_INCREASED →Transitioned To · UTMD CASH_GENERATION_INCREASED →Transitioned To · UTMD GROWTH_INCREASED →Transitioned To · UTMD INVENTORY_PRESSURE_INCREASED →Transitioned To · UTMD MARGIN_DECREASED →Transitioned To · UTMD PROFITABILITY_DECREASED →Transitioned To · UTMD R_AND_D_INTENSITY_DECREASED →Transitioned To · UTMD SBC_INTENSITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.